355 research outputs found
Visual signs and symptoms in patients with the visual variant of Alzheimer disease.
BACKGROUND: Prominent visual symptoms can present in the visual variant of Alzheimer's disease (VVAD). Ophthalmologists have a significant role to play in the early diagnosis of VVAD.
METHODS: We retrospectively reviewed the files of ten consecutive patients diagnosed with VVAD. All patients had a full neuro-ophthalmologic examination, a formal neurological and neuro-psychological testing, and cerebral MRI to confirm diagnosis. In addition, functional neuroimaging was obtained in seven patients.
RESULTS: The common primary symptom at presentation with all patients was difficulty with near vision (reading difficulty n = 8, "visual blur" in near vision n = 2), and difficulty writing (n = 3). Following assessment, impaired reading and writing skills were evident in 9/10 and 8/10 patients respectively. Median distance visual acuity was 20/25 and at near the median visual acuity was J6. Partial homonymous visual field defect was detected in 80 % (8/10) of the patients. Color vision was impaired in all patients when tested with Ishihara pseudoisochromatic plates, but simple color naming was normal in 8/9 tested patients. Simultanagnosia was present in 8/10 patients. Vision dysfunction corresponded with cerebral MRI findings where parieto-occipital cortical atrophy was observed in all patients. PET scan (5 patients) or SPECT (2 patients) revealed parieto-occipital dysfunction (hypometabolism or hypoperfusion) in all 7 tested patients
CONCLUSIONS: Visual difficulties are prominent in VVAD. Dyslexia, incomplete homonymous hemianopia, preserved color identification with abnormal color vision on Ishihara, and simultanagnosia were all symptoms observed frequently in this patient series. Ophthalmologists should be aware of the possibility of neurodegenerative disorders such as VVAD in patients with unexplained visual complaints, in particular reading difficulties
Interhemispheric Visual Integration in Alzheimer's Disease: Decrease of FMRI BOLD Response in VP/V4 Areas.
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients.
BACKGROUND: More than 50% of patients with Parkinson's disease develop motor response fluctuations (the "wearing off" phenomenon) after more than five years of levodopa therapy. Inhibition of catechol-O-methyltransferase by tolcapone has been shown to increase levodopa bioavailability and plasma elimination half life, thereby prolonging the efficacy of levodopa.
OBJECTIVES: The primary objective was to evaluate the efficacy of tolcapone in reducing "wearing off" in levodopa treated, fluctuating parkinsonian patients. Secondary objectives included assessment of reduction in levodopa requirements, improvement in patients' clinical status, duration of improvements, and tolerability of tolcapone.
METHODS: In this multicentre, randomised, double blind, placebo controlled trial, 58 patients received placebo, 60 received 100 mg tolcapone three times daily (tid), and 59 received 200 mg tolcapone tid, in addition to levodopa/benserazide.
RESULTS: After three months with 200 mg tolcapone tid, "off" time decreased by 26.2% of the baseline value, "on" time increased by 20.6% (P<O.01 v placebo), and the mean total daily levodopa dose decreased by 122 mg from the baseline dose of 676 mg (P<0.01). These responses were maintained up to nine months. With 100 mg tolcapone tid, "off" time decreased by 31.5% (P<0.05), "on" time increased by 21.3% (P<0.01), and the mean total daily levodopa dose decreased by 109 mg from the baseline dose of 668 mg (P<0.05). With 200 mg tolcapone tid, unified Parkinson's disease rating scale motor and total scores were significantly reduced, and quality of life (sickness impact profile) scores were significantly improved. Both dosages were well tolerated. Dyskinesia was the most often reported levodopa induced adverse event. Diarrhea was the most often reported non-dopaminergic adverse event and the most frequent reason for withdrawal from the study: four patients in the 100 mg tolcapone tid group and six in the 200 mg tid group withdrew because of diarrhea.
CONCLUSION: Tolcapone prolongs "on" time in fluctuating parkinsonian patients while allowing a reduction in daily levodopa dosage, thereby improving the efficacy of long term levodopa therapy
Statistical mechanics of an ideal Bose gas in a confined geometry
We study the behaviour of an ideal non-relativistic Bose gas in a
three-dimensional space where one of the dimensions is compactified to form a
circle. In this case there is no phase transition like that for the case of an
infinite volume, nevertheless Bose-Einstein condensation signified by a sudden
buildup of particles in the ground state can occur. We use the grand canonical
ensemble to study this problem. In particular, the specific heat is evaluated
numerically, as well as analytically in certain limits. We show analytically
how the familiar result for the specific heat is recovered as we let the size
of the circle become large so that the infinite volume limit is approached. We
also examine in detail the behaviour of the chemical potential and establish
the precise manner in which it approaches zero as the volume becomes large.Comment: 13 pages, 2 eps figures, revtex
Regional Demyelination of Subcortical White Matter in Early Alzheimer's Disease: A Magnetization Transfer Imaging Study.
Coarse-Graining and Renormalization Group in the Einstein Universe
The Kadanoff-Wilson renormalization group approach for a scalar
self-interacting field theor generally coupled with gravity is presented. An
average potential that monitors the fluctuations of the blocked field in
different scaling regimes is constructed in a nonflat background and explicitly
computed within the loop-expansion approximation for an Einstein universe. The
curvature turns out to be dominant in setting the crossover scale from a
double-peak and a symmetric distribution of the block variables. The evolution
of all the coupling constants generated by the blocking procedure is examined:
the renormalized trajectories agree with the standard perturbative results for
the relevant vertices near the ultraviolet fixed point, but new effective
interactions between gravity and matter are present. The flow of the conformal
coupling constant is therefore analyzed in the improved scheme and the infrared
fixed point is reached for arbitrary values of the renormalized parameters.Comment: 18 pages, REVTex, two uuencoded figures. (to appear in Phys. Rev.
D15, July) Transmission errors have been correcte
- …